A chasm has opened up between biomedical researchers and the patients who need their discoveries. Declan Butler asks how the ground shifted and whether the US National Institutes of Health can bridge the gap.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Prioritising and incentivising productivity within indicator-based approaches to Research Impact Assessment: a commentary
Health Research Policy and Systems Open Access 18 December 2023
-
Qualitative evaluation of the implementation of “Tuning in to Kids” in Norwegian Kindergartens
BMC Psychology Open Access 30 March 2023
-
Herausforderungen der Translation von innovativen Produkten und Technologien in die klinische Praxis
Arthroskopie Open Access 28 February 2023
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional information
See also pages 823 and 843, and online at http://tinyurl.com/3tt3y3 Declan Butler is a senior reporter at Nature, based in France.
Related links
Related links
Related links in Nature Research
Related external links
NCRR Clinical and Translational Science Awards
CTSA Clinical and Translational Science Awards
IOM Clinical Research Roundtable
European Advanced Translational Infrastructure in Medicine
Pennyslvania's Institute for Translational Medicine and Therapeutics (ITMAT)
Multiple Myeloma Research Foundation
UK Medical Research Council reforms
Rights and permissions
About this article
Cite this article
Butler, D. Translational research: Crossing the valley of death. Nature 453, 840–842 (2008). https://doi.org/10.1038/453840a
Published:
Issue Date:
DOI: https://doi.org/10.1038/453840a
This article is cited by
-
Qualitative evaluation of the implementation of “Tuning in to Kids” in Norwegian Kindergartens
BMC Psychology (2023)
-
Prioritising and incentivising productivity within indicator-based approaches to Research Impact Assessment: a commentary
Health Research Policy and Systems (2023)
-
The next generation of evidence-based medicine
Nature Medicine (2023)
-
Commercialization of regenerative-medicine therapies
Nature Reviews Bioengineering (2023)
-
Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies
Molecular Psychiatry (2023)